CLAY B SIEGALL Insider Trading for August 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CLAY B SIEGALL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of CLAY B SIEGALL for August 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 25 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 26.10 | 3,831 | 99,989 | 0 | |
Aug 25 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 15.46 | 6,468 | 99,995 | 0 | |
Aug 25 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 15.46 | 6,468 | 99,995 | 729,560 | 723.1 K to 729.6 K (+0.89 %) |
Aug 25 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 26.10 | 3,831 | 99,989 | 723,092 | 719.3 K to 723.1 K (+0.53 %) |
Aug 20 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 158.17 | 27,060 | 4,280,053 | 719,261 | 746.3 K to 719.3 K (-3.63 %) |
Aug 17 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 161.82 | 68,747 | 11,124,640 | 68,747 | |
Aug 17 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 161.82 | 636 | 102,918 | 636 | |
Aug 17 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 27,982 | 0 | 746,321 | 718.3 K to 746.3 K (+3.90 %) |
Aug 17 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 161.82 | 68,747 | 11,124,640 | 68,747 | |
Aug 17 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 161.82 | 636 | 102,918 | 636 | |
Aug 17 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 27,982 | 0 | 746,321 | 718.3 K to 746.3 K (+3.90 %) |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 4,619 | 55,428 | 0 | |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 2,354 | 28,248 | 4,619 | |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 11,616 | 139,392 | 6,973 | |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 9,486 | 113,832 | 18,589 | |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.00 | 400 | 4,800 | 28,075 | |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 154.76 | 4,619 | 714,836 | 718,339 | 723 K to 718.3 K (-0.64 %) |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 4,619 | 55,428 | 722,958 | 718.3 K to 723 K (+0.64 %) |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 155.96 | 2,354 | 367,130 | 718,339 | 720.7 K to 718.3 K (-0.33 %) |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 2,354 | 28,248 | 720,693 | 718.3 K to 720.7 K (+0.33 %) |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 156.89 | 11,616 | 1,822,434 | 718,339 | 730 K to 718.3 K (-1.59 %) |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 11,616 | 139,392 | 729,955 | 718.3 K to 730 K (+1.62 %) |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 157.63 | 9,486 | 1,495,278 | 718,339 | 727.8 K to 718.3 K (-1.30 %) |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 9,486 | 113,832 | 727,825 | 718.3 K to 727.8 K (+1.32 %) |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 158.96 | 400 | 63,584 | 718,339 | 718.7 K to 718.3 K (-0.06 %) |
Aug 13 2020 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.00 | 400 | 4,800 | 718,739 | 718.3 K to 718.7 K (+0.06 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | M | 40.37 | 1,596 | 64,431 | 0 | |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | M | 21.00 | 17,500 | 367,500 | 0 | |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | M | 40.37 | 5,904 | 238,344 | 1,596 | |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Sell | S | 85.01 | 1,596 | 135,676 | 2,550 | 4.1 K to 2.6 K (-38.49 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Buy | M | 40.37 | 1,596 | 64,431 | 4,146 | 2.6 K to 4.1 K (+62.59 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Sell | S | 85.01 | 9,750 | 828,848 | 2,550 | 12.3 K to 2.6 K (-79.27 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Sell | S | 85.55 | 23,404 | 2,002,212 | 12,300 | 35.7 K to 12.3 K (-65.55 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Buy | M | 21.00 | 17,500 | 367,500 | 35,704 | 18.2 K to 35.7 K (+96.13 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Buy | M | 40.37 | 5,904 | 238,344 | 18,204 | 12.3 K to 18.2 K (+48.00 %) |